Michel Delforge

Michel Delforge, MD, PhD, is a professor of medicine in the Department of Haematology at the University of Leuven, in Leuven, Belgium. He studied medicine at the University of Leuven, where he obtained a doctoral degree in biomedical sciences. He continued his medical training as a research fellow at the University of Minnesota, Minneapolis, MN, USA, and subsequently undertook a clinical fellowship at the University of Leuven, with specific interests in myelodysplastic syndromes and plasma cell diseases.
Professor Delforge is currently chair of the KU Leuven Cancer Institute and Clinical Head of the Department of Haematology at the University Hospital Leuven, where he directs the plasma cell dyscrasia unit.with a major focus on multiple myeloma and AL amyloidosis. He is a senior clinical investigator and holds the Fraiture chair in hematology.
Professor Delforge is the current chair of the Myeloma Committee of the Belgian Hematology Society and a member of the Intergroupe Francophone du Myélome, HOVON (Haemato-Oncology Foundation for Adults in the Netherlands), and the International Myeloma Working Group. He has authored or co-authored more than 100 articles in peer-reviewed medical journals and several book chapters in the field of hematology.